By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company SD BioSensor, Inc

SD BioSensor, Inc (137310.KS)

KSC Currency in KRW
₩10.27K
-₩20.00
-0.19%
Last Update: 10 Sept 2025, 06:30
₩1.23T
Market Cap
-11.81
P/E Ratio (TTM)
1.95%
Forward Dividend Yield
₩7.87K - ₩13.55K
52 Week Range

137310.KS Stock Price Chart

Explore SD BioSensor, Inc interactive price chart. Choose custom timeframes to analyze 137310.KS price movements and trends.

137310.KS Company Profile

Discover essential business fundamentals and corporate details for SD BioSensor, Inc (137310.KS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

16 Jul 2021

Employees

576.00

CEO

Hyo Keun Lee

Description

SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.

137310.KS Financial Timeline

Browse a chronological timeline of SD BioSensor, Inc corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 14 May 2025

EPS came in at -₩156.00 , while revenue for the quarter reached ₩185.33B , missing expectations by -13.64%.

Earnings released on 25 Feb 2025

EPS came in at -₩1.10K , while revenue for the quarter reached ₩180.12B , missing expectations by -11.14%.

Dividend declared on 27 Dec 2024

A dividend of ₩200.00 per share was announced, adjusted to ₩200.00. The dividend was paid on 1 Apr 2025.

Earnings released on 13 Nov 2024

EPS came in at ₩532.00 surpassing the estimated -₩199.76 by +366.32%, while revenue for the quarter reached ₩170.61B , missing expectations by -0.64%.

Earnings released on 13 Aug 2024

EPS came in at -₩153.00 surpassing the estimated -₩198.89 by +23.07%, while revenue for the quarter reached ₩167.46B , beating expectations by +0.64%.

Earnings released on 13 May 2024

EPS came in at -₩91.00 , while revenue for the quarter reached ₩176.39B .

Earnings released on 28 Feb 2024

EPS came in at -₩768.00 falling short of the estimated -₩163.13 by -370.79%, while revenue for the quarter reached ₩159.61B , missing expectations by -5.83%.

Earnings released on 13 Nov 2023

EPS came in at -₩552.00 falling short of the estimated -₩209.55 by -163.42%, while revenue for the quarter reached ₩151.03B , missing expectations by -12.75%.

Earnings released on 11 Aug 2023

EPS came in at -₩806.25 , while revenue for the quarter reached ₩162.64B , missing expectations by -7.01%.

Earnings released on 15 May 2023

EPS came in at -₩2.17K , while revenue for the quarter reached ₩182.40B , missing expectations by -47.97%.

Earnings released on 20 Feb 2023

EPS came in at -₩3.19K , while revenue for the quarter reached ₩197.39B , missing expectations by -18.95%.

Dividend declared on 28 Dec 2022

A dividend of ₩290.00 per share was announced, adjusted to ₩290.00. The dividend was paid on 14 Apr 2023.

Earnings released on 3 Nov 2022

EPS came in at ₩4.17K surpassing the estimated ₩1.56K by +166.64%, while revenue for the quarter reached ₩551.16B , beating expectations by +34.35%.

Earnings released on 3 Aug 2022

EPS came in at ₩3.36K surpassing the estimated ₩2.62K by +28.44%, while revenue for the quarter reached ₩795.01B , beating expectations by +6.64%.

Dividend declared on 29 Jun 2022

A dividend of ₩700.00 per share was announced, adjusted to ₩700.00. The dividend was paid on 31 Aug 2022.

Earnings released on 12 May 2022

EPS came in at ₩4.59K , while revenue for the quarter reached ₩1.39T , beating expectations by +18.48%.

Earnings released on 25 Feb 2022

EPS came in at ₩1.28K surpassing the estimated ₩1.18K by +8.94%, while revenue for the quarter reached ₩443.76B , missing expectations by -24.20%.

Dividend declared on 29 Dec 2021

A dividend of ₩1.27K per share was announced, adjusted to ₩1.27K. The dividend was paid on 15 Apr 2022.

Earnings released on 15 Nov 2021

EPS came in at ₩2.11K , while revenue for the quarter reached ₩526.70B .

Earnings released on 13 Aug 2021

EPS came in at ₩3.06K , while revenue for the quarter reached ₩780.39B .

Earnings released on 14 May 2021

EPS came in at ₩3.38K , while revenue for the quarter reached ₩930.94B .

Earnings released on 31 Mar 2021

EPS came in at ₩4.66K , while revenue for the quarter reached ₩1.18T .

Earnings released on 30 Sept 2020

EPS came in at ₩2.43K , while revenue for the quarter reached ₩535.90B .

137310.KS Stock Performance

Access detailed 137310.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run